Walgreens Sales Rise but CEO Says Turnaround Will ‘Take Time’ – RamaOnHealthcare
4 Articles
4 Articles
Walgreens Boots Alliance says US front-end sales ‘weak’ in Q3 2025
US pharmacy Walgreens Boots Alliance (WBA) saw a 7.2% increase in sales to $39bn in the third quarter of fiscal 2025 (FY25), up 6.9% on a constant currency basis, driven by growth in the US Retail Pharmacy and International segments.The post Walgreens Boots Alliance says US front-end sales ‘weak’ in Q3 2025 appeared first on Retail Insight Network.
Walgreens beats forecast in last few quarters before being taken private
Walgreens Boots Alliance Inc reported quarterly profit that beat Wall Street’s expectations, a hopeful sign as the pharmacy giant prepares to transform into a private company after its market value plummeted due to retail competition and lower prescription drug payments from insurance companies.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium